Compare with KMC SPECIALITY HOSPITALS - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

KRSNAA DIAGNOSTICS vs KMC SPECIALITY HOSPITALS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    KRSNAA DIAGNOSTICS KMC SPECIALITY HOSPITALS KRSNAA DIAGNOSTICS/
KMC SPECIALITY HOSPITALS
 
P/E (TTM) x - 53.4 - View Chart
P/BV x 9.3 17.6 53.1% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 KRSNAA DIAGNOSTICS   KMC SPECIALITY HOSPITALS
EQUITY SHARE DATA
    KRSNAA DIAGNOSTICS
Mar-21
KMC SPECIALITY HOSPITALS
Mar-21
KRSNAA DIAGNOSTICS/
KMC SPECIALITY HOSPITALS
5-Yr Chart
Click to enlarge
High RsNA27 0.0%   
Low RsNA12 0.0%   
Sales per share (Unadj.) Rs998.86.3 15,871.4%  
Earnings per share (Unadj.) Rs284.50.8 36,309.7%  
Cash flow per share (Unadj.) Rs342.11.2 29,450.4%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %NM0- 
Book value per share (Unadj.) Rs355.53.9 9,154.4%  
Shares outstanding (eoy) m6.50163.09 4.0%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x03.1 0.0%   
Avg P/E ratio x024.7 0.0%  
P/CF ratio (eoy) x016.7 0.0%  
Price / Book Value ratio x05.0 0.0%  
Dividend payout %00-   
Avg Mkt Cap Rs m03,157 0.0%   
No. of employees `000NANA-   
Total wages/salary Rs m296215 137.5%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m6,4921,026 632.6%  
Other income Rs m12225 480.4%   
Total revenues Rs m6,6151,052 628.9%   
Gross profit Rs m3,466228 1,517.5%  
Depreciation Rs m37462 607.2%   
Interest Rs m25912 2,203.9%   
Profit before tax Rs m2,955180 1,637.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,10553 2,099.6%   
Profit after tax Rs m1,849128 1,447.1%  
Gross profit margin %53.422.3 239.9%  
Effective tax rate %37.429.2 128.2%   
Net profit margin %28.512.5 228.8%  
BALANCE SHEET DATA
Current assets Rs m2,481261 949.7%   
Current liabilities Rs m1,838126 1,464.6%   
Net working cap to sales %9.913.2 74.9%  
Current ratio x1.42.1 64.8%  
Inventory Days Days2563 39.3%  
Debtors Days Days419,084 0.4%  
Net fixed assets Rs m3,564934 381.4%   
Share capital Rs m2,489163 1,526.1%   
"Free" reserves Rs m-178470 -37.9%   
Net worth Rs m2,310633 364.9%   
Long term debt Rs m1,680257 652.6%   
Total assets Rs m6,0451,196 505.6%  
Interest coverage x12.416.3 75.9%   
Debt to equity ratio x0.70.4 178.9%  
Sales to assets ratio x1.10.9 125.1%   
Return on assets %34.911.7 298.8%  
Return on equity %80.020.2 396.6%  
Return on capital %80.521.6 373.2%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m00-   
Fx outflow Rs m00-   
Net fx Rs m00-   
CASH FLOW
From Operations Rs m1,026256 400.5%  
From Investments Rs m-611-426 143.6%  
From Financial Activity Rs m308180 171.4%  
Net Cashflow Rs m72310 7,042.8%  

Share Holding

Indian Promoters % 27.4 75.0 36.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 34.6 0.0 -  
FIIs % 4.4 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 72.6 25.0 290.5%  
Shareholders   75,065 77,927 96.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare KRSNAA DIAGNOSTICS With:   FORTIS HEALTHCARE    INDRAPRASTHA MEDICAL    THYROCARE TECHNOLOGIES    DR. LAL PATHLABS    METROPOLIS HEALTHCARE    



Today's Market

Sensex Sheds 427 Points, Nifty Ends Near 17,600; Bajaj Finserv, Tata Steel & Tech Mahindra Top Losers(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended on a weak note.

Related Views on News

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

More Views on News

Most Popular

10 Indian Companies with the Fastest Growth in Dividend Payouts...(Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain(Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

Time to Buy Energy Stocks(Fast Profits Daily)

Jan 14, 2022

Energy is a sector that looks set to take off. It's time to get in.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

KRSNAA DIAGNOSTICS SHARE PRICE


Jan 21, 2022 (Close)

TRACK KRSNAA DIAGNOSTICS

  • Track your investment in KRSNAA DIAGNOSTICS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON KRSNAA DIAGNOSTICS

KRSNAA DIAGNOSTICS - FORTIS MALAR COMPARISON

COMPARE KRSNAA DIAGNOSTICS WITH

MARKET STATS